Expression Quantitative Trait Loci (eQTL)

An expression quantitative trait locus (eQTL) is a genomic region — usually marked by a genetic variant — whose alleles are statistically associated with the expression level of one or more genes. Treating transcript abundance as a quantitative phenotype, eQTL mapping links the genome to the transcriptome and provides a mechanism by which non-coding variants, including many disease-associated ones, can influence biology by tuning how much a gene is expressed.

Definition

An expression quantitative trait locus is a locus at which genetic variation is associated with variation in the expression level of a gene; eQTL mapping identifies such loci by testing the statistical association between genotype and measured transcript abundance.

Scope

This topic covers the concept and mapping of eQTLs: the distinction between local (cis) and distant (trans) effects, the regression of expression on genotype, tissue and cell-type dependence, and the use of eQTLs to interpret genome-wide association signals through colocalization. It is a methodological and conceptual reference within transcriptomics and provides no clinical guidance.

Core questions

• Which genetic variants are associated with the expression level of which genes?
• Does a variant act locally on a nearby gene (cis) or distantly on genes elsewhere (trans)?
• How do eQTL effects vary across tissues and cell types?
• How can eQTLs help explain the function of disease-associated non-coding variants?

Key concepts

• Expression as a quantitative phenotype
• Cis-eQTL versus trans-eQTL
• Genotype-expression association testing
• Tissue and cell-type specificity
• Allelic expression imbalance
• Colocalization with GWAS signals
• Multiple-testing correction across genes and variants

Mechanisms

eQTL mapping pairs genotype data with transcriptome measurements from the same individuals and, for each gene, tests whether expression varies systematically with the alleles at nearby or genome-wide variants, typically by regression. Variants near the gene they affect are termed cis-eQTLs and often act by altering promoters, enhancers, or transcript stability, whereas trans-eQTLs act at a distance, frequently through intermediate regulators such as transcription factors. Because regulatory effects are often context-specific, the same variant may be an eQTL in one tissue or cell type but not another, as Dimas and colleagues showed for cell-type dependence and as the GTEx atlas mapped across many human tissues. When an eQTL coincides with a disease-association signal, colocalization analysis can suggest that the variant influences the trait by regulating that gene's expression; transcriptome-and-genome sequencing studies such as Lappalainen and colleagues further linked variants to both expression level and transcript structure.

Clinical relevance

eQTLs are central to interpreting the large fraction of disease-associated variants that fall in non-coding regions, by nominating the genes whose regulation those variants alter. As a reference topic this entry explains how genotype-to-expression links are established and used in research; it is not a basis for individual diagnostic or treatment decisions.

Evidence & guidelines

Reference resources include population eQTL studies (Dimas and colleagues; Lappalainen and colleagues) and the GTEx atlas, which together define standard approaches to cis/trans mapping, tissue specificity, and integration with association studies. These are methodological references rather than clinical guidelines.

History

The idea of treating gene expression as a heritable quantitative trait took hold in the 2000s, as genome-wide genotyping was combined with expression profiling to map cis and trans regulatory variants. Studies through 2009 established cell-type and tissue dependence of eQTL effects, sequencing-based studies around 2013 linked variants to both expression level and isoform usage, and the GTEx project then produced a tissue-wide reference atlas of genetic regulatory effects.

Debates

Detecting and replicating trans-eQTLs

Cis-eQTLs are comparatively easy to detect because effects are local and testing is restricted, whereas trans-eQTLs require genome-wide testing, have smaller effects, and are harder to replicate, leaving the full landscape of distant regulation incompletely mapped.

Key figures

• Emmanouil Dermitzakis
• Tuuli Lappalainen
• Barbara Stranger

Seminal works

• dimas-2009
• lappalainen-2013
• gtex-2020

Frequently asked questions

What is the difference between a cis-eQTL and a trans-eQTL?

A cis-eQTL is a variant located near the gene whose expression it affects and usually acts locally, for example on a promoter or enhancer. A trans-eQTL affects a gene far away in the genome, often indirectly through an intermediate regulator such as a transcription factor.

Why are eQTLs useful for interpreting GWAS hits?

Many disease-associated variants lie in non-coding DNA and do not change a protein directly. If such a variant is also an eQTL, it points to the gene whose expression it regulates, offering a plausible mechanism for how the variant influences the trait.